Business Context and Reporting Period
Company: Global Medical REIT Inc. (GMRE)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2024
Business Overview: An internally managed REIT that acquires healthcare facilities and leases them to physician groups and healthcare systems. The portfolio consists primarily of outpatient medical buildings under triple-net leases.
Key Financial Metrics
| Metric | Q3 2024 (3 Months) | Q3 2023 (3 Months) | YTD 2024 (9 Months) | YTD 2023 (9 Months) |
|---|---|---|---|---|
| Total Revenue | $34.3 million | $35.5 million | $103.6 million | $108.1 million |
| Net Income | $3.4 million | $4.8 million | $3.8 million | $21.2 million |
| Net Income (Loss) Attributable to Common Stockholders | $1.8 million | $3.1 million | $(0.6) million | $15.6 million |
| Diluted EPS (Common) | $0.03 | $0.05 | $(0.01) | $0.24 |
| FFO per Share/Unit | $0.19 | $0.22 | $0.60 | $0.64 |
| AFFO per Share/Unit | $0.22 | $0.23 | $0.67 | $0.69 |
| Cash and Restricted Cash | $7.8 million (as of Sept 30, 2024) | |||
| Total Debt (Net) | $628.9 million (as of Sept 30, 2024) | |||
| Weighted Avg Interest Rate | 3.79% (as of Sept 30, 2024) |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased by 3.5% in Q3 and 4.1% YTD compared to 2023. This was driven by portfolio changes, including the full-year impact of 2023 dispositions and reduced occupancy in 2024.
- Net Income Volatility: YTD Net Income dropped significantly from $21.2 million in 2023 to $3.8 million in 2024. The 2023 period included a $15.6 million gain on the sale of an Oklahoma City portfolio, whereas the 2024 period included a $1.6 million aggregate loss on property sales.
- Property Transactions:
- Acquisitions: Completed 5 acquisitions in July 2024 (part of a 15-property portfolio) for $30.8 million. The remaining 10 properties were acquired in October 2024.
- Dispositions: Sold 3 properties in 2024. Notably, the sale of a Mishawaka, IN facility resulted in a $3.4 million loss, offset by gains on two Florida properties.
- Debt Activity: Net borrowings under the Credit Facility increased by $27.4 million YTD. The Revolver balance increased to $119.8 million.
Guidance, Outlook, and Risks
- Capital Raising: The Company utilized its $300 million "at-the-market" (ATM) equity program, raising $12.0 million in the first nine months of 2024 at an average price of $9.95 per share.
- Interest Rate Environment: Management notes that while the Federal Reserve cut rates in September 2024, elevated rates continue to constrain asset acquisition opportunities and increase the cost of capital. The Company has hedged $500 million of its debt via interest rate swaps.
- Dividends: Common stock dividends remained stable at $0.21 per share for the quarter. Preferred dividends were $0.46875 per share.
- Risks:
- Tenant Credit: Risks associated with healthcare wage inflation and third-party reimbursement changes affecting tenant ability to pay rent.
- Liquidity: Dependence on the Credit Facility and equity markets for growth capital.
- Market Conditions: Potential for decreased rental rates or increased vacancy rates in a high-interest environment.
Investor Verification Checklist
- Disposition Losses: Verify the impact of the $3.4 million loss on the Mishawaka facility sale on future earnings and portfolio strategy.
- Occupancy Trends: Confirm current occupancy rates and the specific impact of tenants placed on cash-basis accounting mentioned in the MD&A.
- Debt Covenants: Review compliance with the Credit Facility covenants, specifically the maximum consolidated leverage ratio of 60% and minimum fixed charge coverage ratio of 1.50:1.00.
- Acquisition Pipeline: Assess the status of the remaining 10 properties from the 15-property portfolio acquired in October 2024 and the new 5-property portfolio under contract for $69.6 million.
- Interest Rate Sensitivity: Evaluate the exposure of the $119.8 million unhedged revolver balance to further SOFR fluctuations.